MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
New Jersey
Venture Capital & Angel Investors: New Jersey
Venture Capital: New Jersey
Foundation Venture Capital Group
Longevica Pharmaceuticals
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
*Industry: New Jersey
An affiliate of New Jersey Health Foundation it invests in commercially viable new start-up companies developing technology by faculty at UMDNJ. Since that time it has invested in five companies including:
Companies: Acquired_(M&A)
Foundation Venture Capital Group
Children
Developing a chemoprotective agent that may keep normal cells healthy during cancer treatments (FVCG's equity interest in Longevica was recently sold to Rostock International, LTD, a subsidiary of a Moscow (Russia) based global investment firm)
Jumps
Venture Capital: Russia